Cargando…

1290. Impact of Implementing an IV to PO Antibiotic Treatment Protocol for Orthopedic Infections

BACKGROUND: Oral (PO) regimens have been utilized more frequently for orthopedic infections in place of intravenous (IV) regimens at our center following publication of the OVIVA trial. Given limited published experience of this approach at US medical centers, we reviewed safety and effectiveness ou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gray, Julie, Benefield, Russell J, Cummins, Heather, Certain, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676857/ http://dx.doi.org/10.1093/ofid/ofad500.1129

Ejemplares similares

909. Impact of Implementing an IV to PO Antibiotic Treatment Protocol for Orthopedic Infections on Prescribing Habits and Health Utilization Outcomes
por: Gallagher, Chanah, et al.
Publicado: (2022)

1829. The Impact of Social Determinants of Health on Treatment Route, Duration, and Outcomes in Bone and Joint Infections
por: Cummins, Heather, et al.
Publicado: (2023)

232. Safety and Effectiveness of Intravenous to Oral De-escalation Compared to Continued Vancomycin Therapy in Orthopedic Infections
por: Gallagher, Chanah, et al.
Publicado: (2021)

588. Implementation of a standardized OPAT SmartForm was associated with improved post-discharge outcomes
por: Certain, Laura, et al.
Publicado: (2020)

748. Does Improving Discharge Documentation Improve Post-Discharge Care for Patients on Outpatient Parenteral Antimicrobial Therapy (OPAT)?
por: Certain, Laura, et al.
Publicado: (2019)

602. Do These Labs Really Matter? Searching for the Benefit of Laboratory Monitoring in Outpatient Parenteral Antimicrobial Therapy (OPAT)
por: Zukauckas, Kelsea N, et al.
Publicado: (2020)

604. Factors Associated with Adverse Drug Reactions Leading to Discontinuation of Vancomycin in Outpatient Parenteral Antimicrobial Therapy
por: McDonald, Josh, et al.
Publicado: (2020)

218. IV to PO Conversion of Antimicrobials: Small Intervention, Big Impact
por: Wei, Wenjing, et al.
Publicado: (2018)

296. IV-to-PO Antibiotic Step-down Therapy for Treatment of Uncomplicated Streptococcal Bloodstream Infections
por: Ramos-Otero, Gerardo P, et al.
Publicado: (2020)

1290. A Model for “At-Distance” PrEP Navigation: Acceptability and Early Insights
por: Perlson, Jacob, et al.
Publicado: (2018)

608. Continuous Infusion Vancomycin Is Not Associated with Improved Safety in an Outpatient Parenteral Antimicrobial Therapy Program
por: Tagare, Rosemarie D, et al.
Publicado: (2021)

1290. Real-World Experience with Omadacycline for Nontuberculous Mycobacterial and Gram-Negative Infections: A Multicenter Evaluation
por: Morrisette, Taylor, et al.
Publicado: (2020)

1290. Ceftazidime-Avibactam Resistance Report in a Third Level Hospital in Mexico City
por: Molina, Aaron, et al.
Publicado: (2021)

259. A Prospective, Stewardship-Driven IV to PO Conversion in Uncomplicated Bacteremia
por: Quan, Asia, et al.
Publicado: (2020)

Efficacy and safety of sequential IV/PO moxifloxacin for the treatment of severe community-acquired pneumonia
por: Lode, H, et al.
Publicado: (2002)

A Quality Initiative to Improve Postdischarge Care for Patients on Outpatient Parenteral Antimicrobial Therapy
por: Certain, Laura K, et al.
Publicado: (2022)

2072. Do ID and Non-ID Clinicians Agree on IV to PO Switch Criteria? Results from Phase I of the INForming IV to ORal MEdication Report (INFORMER) Project
por: Bosma, Rachael, et al.
Publicado: (2019)

981. Inducing Antimicrobial Resistance with Long-Term Antibiotics at Stage 2 Revision for Periprosthetic Joint Infection
por: Payne, Judd, et al.
Publicado: (2022)

1936. Implementation of IV Push Antibiotics for OPAT in a Safety Net Hospital Following a National Fluid Shortage
por: Bhavan, Kavita, et al.
Publicado: (2018)

2109. Liposomal Amphotericin B-associated Nephrotoxicity in Obese and Non-obese Patients
por: Tritle, Brandon, et al.
Publicado: (2019)

1290. Community Screening and Education for HIV and Hepatitis C (HCV) infection in South Texas with Rapid Point of Care Testing and a Mobile Phone Application (app)
por: Allison, Waridibo E, et al.
Publicado: (2019)

2061. Private Practice Dentists and Orthopedic Surgeons (PPD&OS) Engage in a Novel Stewardship Forum: Consensus to Use Less Antibiotics Achieved
por: Goff, Debra A, et al.
Publicado: (2019)

Impact of a Rapid Diagnostic for Bloodstream Infections with Antimicrobial Stewardship Intervention at a Comprehensive Cancer Center
por: Buss, Brian, et al.
Publicado: (2017)

201. Safety and Effectiveness of Daily vs. Every Other Day Dosing of Daptomycin in Patients with Renal Insufficiency
por: Oliver, Meredith, et al.
Publicado: (2019)

124. Implementation of IV Push Antibiotics for Outpatients During a National Fluid Shortage Following Hurricane Maria
por: Yagnik, Kruti J, et al.
Publicado: (2021)

1591. Infectious Outcomes of Levofloxacin Prophylaxis in Obese vs. Non-obese Patients with Hematologic Malignancies
por: Kurtti, Amanda, et al.
Publicado: (2018)

The use of an IV to PO clinical intervention form to improve antibiotic administration in a community based hospital
por: Thompson, Cameron, et al.
Publicado: (2015)

Evidence for a non-strange meson of mass 1290 MeV
por: D'Andlau, C, et al.
Publicado: (1965)

An Insight into miR-1290: An Oncogenic miRNA with Diagnostic Potential
por: Guz, Małgorzata, et al.
Publicado: (2022)

Circulating Exosomal miR-1290 for Diagnosis of Epithelial Ovarian Cancer
por: Jeon, Hyeji, et al.
Publicado: (2022)

621. Identifying Quality-Improvement Interventions to Improve Inpatient Intravenous Vancomycin Safety at an Academic Medical Center
por: Christensen, Sean, et al.
Publicado: (2021)

Antibiotics in Orthopedic Infections
por: Anagnostakos, Konstantinos, et al.
Publicado: (2021)

Reduction in Antibiotic Consumption Upon Implementation of Antibiotic Indication Requirement
por: Beth Marshall, Mary, et al.
Publicado: (2017)

The type IV polymorph of KEu(PO(3))(4)
por: Oudahmane, Abdelghani, et al.
Publicado: (2009)

Structure within the R(1675) boson and possible structure within the A(1290)
por: Levrat, B, et al.
Publicado: (1966)

Serum Exosomal miR-1290 is a Potential Biomarker for Lung Adenocarcinoma
por: Wu, Yining, et al.
Publicado: (2020)

A Review on the Role of miR-1290 in Cell Proliferation, Apoptosis and Invasion
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2021)

Impact of an Automatic Hospital Probiotic Protocol on Clostridium difficile Infection Rates and Antibiotic Usage Patterns
por: Slain, Douglas, et al.
Publicado: (2017)

159. Comparing Clinical Cure and Patient Outcomes Between Intravenous Therapy and Intravenous (IV)-to-Oral (PO) Step-down Therapy for Treatment of Gram-Negative Bloodstream Infections
por: Williams, Kelsey, et al.
Publicado: (2019)

166. Impact of Pneumonia Panel Implementation with Stewardship Support on Antibiotic De-escalation in the ICU
por: Schooneveld, Trevor C Van, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8k24eoe3fikqlhauc0g23u83ka